Some kinetic and inhibition properties of human brain mitochondrial monoamine oxidase (EC 1.4.3.4).
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D001921:Brain / Q000201:enzymology*; D001923:Brain Chemistry; D002250:Carbon Radioisotopes; D003907:Dexamethasone / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D013759:Dronabinol / Q000494:pharmacology; D004966:Estrogens, Conjugated (USP) / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D006213:Hallucinogens / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008928:Mitochondria / Q000201:enzymology*; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors; D009638:Norepinephrine / Q000378:metabolism; D011239:Prednisolone / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013739:Testosterone / Q000494:pharmacology; D014363:Tryptamines / Q000378:metabolism
D002250:Carbon Radioisotopes; D004966:Estrogens, Conjugated (USP); D006213:Hallucinogens; D008996:Monoamine Oxidase Inhibitors; D014363:Tryptamines; D012701:Serotonin; D000431:Ethanol; D013739:Testosterone; D011374:Progesterone; D013759:Dronabinol; D003907:Dexamethasone; D008238:Lysergic Acid Diethylamide; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D000661:Amphetamine; D008995:Monoamine Oxidase; D004298:Dopamine; D009638:Norepinephrine